Glucagon-Like Peptide-1 Receptor Agonist Market Set for Rapid...

added article Other

2023-12-28 08:51:24 -

Glucagon-Like Peptide-1 Receptor Agonist Market Set for Rapid Growth due to The increasing awareness about glycemic control

GLP-1 receptor agonists are incretin mimetic drugs commonly used for glycemic control in type 2 diabetes. They work by stimulating the release of insulin from pancreatic beta cells and suppressing glucagon secretion. GLP-1 receptor agonists provide effective glycemic control along with weight loss benefits and low risk of hypoglycemia. The growing prevalence of diabetes and obesity has fueled...

0 Comments 0 Shares 1172 Views 0 Reviews